Trial NCT02906020

View at ClinicalTrials.gov 
Org. Study IDs: ACT14820
Secondary IDs: 2016-000657-12 U1111-1180-6918

Last trial update was posted on 2022-05-24

MeSH Interventions

Venglustat

MeSH Conditions

Parkinson Disease

Other Conditions

Parkinson's Disease

Stopping Reasons

The topline results of the 52-week double-blind placebo-controlled period were analyzed. The study did not meet the primary or secondary endpoints. Based on these results, the decision was made to halt the long-term follow-up period of the study

Limitations And Caveats

This study did not achieve its primary or secondary endpoints at the time of the analysis of the double-blind 52-week treatment period of Part 2 and was terminated early.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID